跳至主要内容
临床试验/NCT07646938
NCT07646938已完成不适用

A Prospective, Clinical Evaluation of the MolecuLightDX+ With OxySight Module to Observe the Clinical Utility of Tissue Oxygenation, Bacterial Fluorescence and Thermal Signatures

MolecuLight Inc.1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2026年3月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
18
试验地点
1
主要终点
Tissue oxygenation informing fluorescence-guided debridement

研究概览

简要总结

This is a prospective, clinical evaluation of the MolecuLightDX+ with OxySight Module in wound care.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patients presenting with a wound
  • A wound is > 1 cm2 in area
  • 18+ years old
  • Willing to consent

排除标准

  • Contraindication to debridement
  • Undergoing radio- or chemotherapy
  • Wound located in a difficult to image location
  • Any condition deemed by the investigator to interfere with safety or data validity
  • Inability or unwillingness to consent

结局指标

主要结局

Tissue oxygenation informing fluorescence-guided debridement

时间窗: up to 1 month

Evaluate the feasibility of using tissue oxygenation (StO2) to further inform fluorescence-guided debridement.

Tissue oxygenation changes before and after debridement

时间窗: up to 1 month

Observe and quantify changes in tissue oxygenation (StO2) from before to immediately after fluorescence-guided debridement.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验